Cambridge Investment Research Advisors Inc. bought a new stake in Dr Pepper Snapple Group, Inc (NYSE:DPS) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 23,331 shares of the company’s stock, valued at approximately $2,126,000.

Several other large investors have also recently modified their holdings of DPS. Huntington National Bank boosted its stake in shares of Dr Pepper Snapple Group by 5.4% in the first quarter. Huntington National Bank now owns 1,100 shares of the company’s stock valued at $108,000 after buying an additional 56 shares during the period. Parallel Advisors LLC boosted its stake in shares of Dr Pepper Snapple Group by 34.9% in the second quarter. Parallel Advisors LLC now owns 1,211 shares of the company’s stock valued at $110,000 after buying an additional 313 shares during the period. Meeder Asset Management Inc. purchased a new stake in shares of Dr Pepper Snapple Group during the first quarter valued at about $113,000. Financial Architects Inc boosted its stake in shares of Dr Pepper Snapple Group by 4.8% in the second quarter. Financial Architects Inc now owns 1,322 shares of the company’s stock valued at $121,000 after buying an additional 61 shares during the period. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in shares of Dr Pepper Snapple Group by 3.2% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 1,817 shares of the company’s stock valued at $178,000 after buying an additional 57 shares during the period. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Dr Pepper Snapple Group, Inc (NYSE DPS) opened at 91.05 on Friday. The firm’s 50 day moving average price is $91.01 and its 200 day moving average price is $93.09. Dr Pepper Snapple Group, Inc has a 12 month low of $81.05 and a 12 month high of $99.47. The stock has a market cap of $16.55 billion, a price-to-earnings ratio of 21.83 and a beta of 0.60.

Dr Pepper Snapple Group (NYSE:DPS) last announced its quarterly earnings results on Thursday, July 27th. The company reported $1.25 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.03. The firm had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.77 billion. Dr Pepper Snapple Group had a return on equity of 38.28% and a net margin of 11.73%. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.25 EPS. On average, equities research analysts predict that Dr Pepper Snapple Group, Inc will post $4.63 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 5th. Stockholders of record on Thursday, September 14th will be issued a dividend of $0.58 per share. The ex-dividend date is Wednesday, September 13th. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.55%. Dr Pepper Snapple Group’s dividend payout ratio is currently 55.64%.

COPYRIGHT VIOLATION WARNING: “Cambridge Investment Research Advisors Inc. Takes Position in Dr Pepper Snapple Group, Inc (DPS)” was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.watchlistnews.com/cambridge-investment-research-advisors-inc-takes-position-in-dr-pepper-snapple-group-inc-dps/1535819.html.

Several research analysts recently commented on DPS shares. Jefferies Group LLC reiterated a “buy” rating and issued a $112.00 price target on shares of Dr Pepper Snapple Group in a research report on Thursday, July 6th. Susquehanna Bancshares Inc set a $96.00 price target on Dr Pepper Snapple Group and gave the stock a “hold” rating in a research report on Thursday, July 27th. Zacks Investment Research upgraded Dr Pepper Snapple Group from a “hold” rating to a “buy” rating and set a $104.00 price target for the company in a research report on Tuesday, June 27th. Royal Bank Of Canada reiterated a “hold” rating and issued a $91.00 price target on shares of Dr Pepper Snapple Group in a research report on Friday, June 9th. Finally, Credit Suisse Group set a $107.00 price target on Dr Pepper Snapple Group and gave the stock a “buy” rating in a research report on Thursday, July 27th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $99.64.

In other news, insider Angela A. Stephens sold 3,160 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $92.51, for a total transaction of $292,331.60. Following the completion of the sale, the insider now owns 16,913 shares in the company, valued at approximately $1,564,621.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.58% of the stock is owned by company insiders.

About Dr Pepper Snapple Group

Dr Pepper Snapple Group, Inc is an integrated brand owner, manufacturer and distributor of non-alcoholic beverages in the United States, Mexico and Canada. The Company offers a diverse portfolio of flavored (non-cola) carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks, water and mixers.

Institutional Ownership by Quarter for Dr Pepper Snapple Group (NYSE:DPS)

Receive News & Ratings for Dr Pepper Snapple Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr Pepper Snapple Group Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.